EFFECT OF ORALLY ACTIVE HYDROXYPYRIDINONE IRON CHELATORS ON HUMAN LYMPHOCYTE FUNCTION

被引:17
作者
PATTANAPANYASAT, K
WEBSTER, HK
TONGTAWE, P
KONGCHAROEN, P
HIDER, RC
机构
[1] ARMED FORCES RES INST MED SCI,DEPT IMMUNOL & BIOCHEM,BANGKOK,THAILAND
[2] UNIV LONDON KINGS COLL,DEPT PHARM,LONDON WC2R 2LS,ENGLAND
关键词
D O I
10.1111/j.1365-2141.1992.tb04587.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several iron chelators, 3-hydroxypyridin-4-ones (CP) and desferrioxamine (DF) were compared for their effect on DNA synthesis, cell viability and expression of cell proliferation markers. Short-term (4 h) exposure of human peripheral blood mononuclear cells to CP or DF inhibited the proliferative response of cells to concanavalin A (Con A). Inhibition by CP and DF showed a dose-dependent effect with CP compounds more active than DF. Increased inhibitory activity of CP over DF was partly due to the lipophilic properties of CP. Pre-saturation of CP and DF with exogenous ferric ion either diminished or prevented the inhibitory effect. At high chelator concentrations or prolonged (72 h) exposure of the cells to chelators, inhibition occurred but poor cell viability was observed. In contrast to their inhibition of DNA synthesis, these iron chelators showed little effect on protein synthesis and the expression of transferrin receptors and interleukin-2 (IL-2) receptors. These findings suggest that both DF and CP compounds exert their effect by chelation of ferric ion with subsequent inhibition of DNA synthesis.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 33 条
  • [1] UPTAKE AND RELEASE OF TRANSFERRIN AND IRON BY MITOGEN-STIMULATED HUMAN-LYMPHOCYTES
    BOMFORD, A
    YOUNG, SP
    NOURIARIA, K
    WILLIAMS, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (01) : 93 - 101
  • [2] BRIDGES KR, 1984, J BIOL CHEM, V259, P2970
  • [3] SPECTRUM AND IRON CONTENT OF PROTEIN B2 FROM RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE
    BROWN, NC
    ELIASSON, R
    REICHARD, P
    THELANDER, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 9 (04): : 512 - +
  • [4] CAROTENUTO P, 1986, J IMMUNOL, V136, P2342
  • [5] CHAUDHRI G, 1986, J IMMUNOL, V137, P2646
  • [6] EFFECT OF IRON-CHELATING AGENTS ON INHIBITORS OF RIBONUCLEOTIDE REDUCTASE
    CORY, JG
    LASATER, L
    SATO, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (09) : 979 - 984
  • [7] EFFECT OF VARIOUS IRON CHELATING-AGENTS ON DNA-SYNTHESIS IN HUMAN-CELLS
    GANESHAGURU, K
    HOFFBRAND, AV
    GRADY, RW
    CERAMI, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (09) : 1275 - 1279
  • [8] INVIVO EVALUATION OF HYDROXYPYRIDONE IRON CHELATORS IN A MOUSE MODEL
    GYPARAKI, M
    PORTER, JB
    HIRANI, S
    STREATER, M
    HIDER, RC
    HUEHNS, ER
    [J]. ACTA HAEMATOLOGICA, 1987, 78 (2-3) : 217 - 221
  • [9] EVALUATION INVIVO OF HYDROXYPYRID-4-ONE IRON CHELATORS INTENDED FOR THE TREATMENT OF IRON OVERLOAD BY THE ORAL ROUTE
    GYPARAKI, M
    PORTER, JB
    HUEHNS, ER
    HIDER, RC
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (06) : 1181 - 1181
  • [10] HIDER RC, 1984, Patent No. 2146990